Furthermore, RFA-lip-GM-CSF also enhanced the immune microenvironment in the treated tumor beyond the periablational rim, demonstrating that this immune upregulation is not only a by-product of the partial injury and hypervascularity observed in the periablational rim [41], but represents a more global change induced throughout the index tumor. The gene discussed is CSF2; the disease is neoplasm.